Antony Odell

Antony Odell is an experienced executive with a long career in the medical technology industry. He was appointed as Executive Chairman of Tandem Nano Ltd, a University of Liverpool spin-out company, in 2019.15 Odell's role at Tandem Nano Ltd is to accelerate the commercialization of the company's proprietary technology for reformulating poorly soluble pharmaceuticals and chemicals.1

Key points about Antony Odell:

1. Career background:

   • Over 30 years of experience in medical technology5
   • Held senior business roles at multinational companies like Johnson & Johnson3
   • Focused on nurturing innovation in early-stage medical technology start-ups3

2. Notable achievements:

   • Former CEO of Tissue Regenix Group plc, which he led from laboratory proof of concept to an AIM-listed business with international operations13
   • Successfully built and expanded businesses in various fields5

3. Current roles:

   • CEO of Echopoint Medical Ltd, developing optical-fiber based sensors for interventional cardiology procedures24
   • CEO of Tandem Nano Ltd, focusing on the SDN (Solid Drug Nanoparticle) technology platform35

4. Expertise:

   • Experienced in developing and commercializing both early and late-stage medical technology5
   • Skilled in devising strategic business plans considering clinical, regulatory, and reimbursement landscapes3
   • Focuses on creating sustainable exit strategies for optimal investor returns3

5. Other positions:

   • Board Director of NorthInvest, a major Angel network based in Leeds5
   • Director in several early-stage life science companies5

Antony Odell's LinkedIn username is antonyrodell.6